A phase I study of PXD101 (belinostat) in patients with unresectable hepatocellular carcinoma (HCC): a multicenter study by the Cancer Therapeutics Research Group (CTRG)
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListYEO Winnie, CHAN Lam Stephen, MO Kwok Fai, LIM R, MA Buig Yue Brigette, HUI Pun Edwin, YU S, KOH Chun, CHAN Anthony Tak Cheung, GOH B C
Name of Conference19th Conference of the Asian Pacific Association for the Study of the Liver
Start Date of Conference13/02/2009
Country/Region of ConferenceChina
Proceedings Title19th Conference of the Asian Pacific Association for the Study of the Liver
Year2009
Month2
Day13
Place of PublicationChina, Hong Kong
Pagesp158
LanguagesEnglish-United Kingdom
Keywordshepatocellular carcinoma; PXD101

Last updated on 2018-20-01 at 13:14